PDCD1 and neoplasm: In this study, we aimed to demonstrate the abscopal effect in a preclinical model of metastatic breast cancer using 4T1 tumor and to evaluate whether combined anti-PD-1 antibody and hypofractionated RT with ablative doses could inhibit both irradiated and non-irradiated (primary and secondary, respectively) tumor growth.